BPC-157 + TB-500 Blend 5mg / 5mg
€ 59,00
BPC-157 / TB-500 5 mg / 5 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical testing confirms 99.2 % purity for BPC-157 and greater than 99.8 % purity for TB-500, with assay content verified at 7.36 mg and 6.11 mg respectively. Molecular ion mass identification confirmed 1418 Da for BPC-157 and 4963 Da for TB-500.
Supplied as a dual-peptide lyophilized research blend with full COA traceability.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
Product Overview
BPC-157 / TB-500 combines two extensively studied peptide compounds within a single research preparation designed for controlled laboratory investigations involving peptide signalling systems, molecular communication pathways and peptide interaction models. Both peptides have become widely recognised within scientific literature due to their defined molecular structures, analytical stability and extensive use in peptide-focused research programmes. This preparation contains 5 mg BPC-157 and 5 mg TB-500 supplied as a lyophilized dual-peptide blend. Lyophilization helps preserve peptide stability during storage while allowing controlled reconstitution for laboratory experimentation. The combination remains a frequently referenced research material due to the complementary analytical characteristics of both compounds and their suitability for controlled in vitro investigation.Peptide Overview
BPC-157 is a synthetic peptide research compound frequently investigated in laboratory environments examining peptide signalling systems and molecular interaction pathways. TB-500, the synthetic research form of Thymosin Beta 4, is commonly studied in controlled laboratory settings focused on peptide-mediated biological communication systems and molecular regulatory mechanisms. When supplied together as a research blend, these compounds provide researchers with an opportunity to investigate peptide interaction models, signalling pathways and comparative peptide response systems under controlled laboratory conditions. Their established analytical profiles and continued presence within scientific literature have contributed to ongoing interest across multiple fields of peptide research.Historical Background and Scientific Context
Scientific interest in synthetic peptides expanded substantially as advances in analytical chemistry and peptide synthesis enabled researchers to investigate increasingly complex molecular communication systems. BPC-157 and TB-500 subsequently emerged as recognised research compounds due to their defined structures, reproducible analytical characteristics and suitability for controlled experimental investigations. Over time, both peptides have appeared in numerous scientific publications examining peptide signalling dynamics, molecular interaction pathways and regulatory communication systems. These investigations continue to contribute valuable knowledge regarding peptide-mediated biological processes and molecular signalling mechanisms.Mechanistic Focus in Research
Within controlled laboratory settings, BPC-157 / TB-500 is commonly studied in relation to peptide-mediated signalling pathways and molecular communication systems. Research investigations frequently explore:- Peptide signalling pathways
- Molecular interaction dynamics
- Cellular communication systems
- Signal transduction mechanisms
- Comparative peptide pathway analysis
- Peptide-mediated regulatory systems
- Laboratory peptide interaction modelling
Analytical Verification (COA)
Each batch of BPC-157 / TB-500 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, microbiological and mass spectrometry techniques. Batch: GF-BPCTB5-B241- BPC-157 Assay: 7.36 mg
- BPC-157 Purity: 99.2 percent
- BPC-157 Identification by RT: 0.995
- Molecular Ion Mass Identification (BPC-157): 1418 Da
- TB-500 Assay: 6.11 mg
- TB-500 Purity: greater than 99.8 percent
- TB-500 Identification by RT: 0.996
- Molecular Ion Mass Identification (TB-500): 4963 Da
- Bacterial Endotoxins: below 0.001 EU/mg
- Total Aerobic Microbial Count: Not detected
- Total Yeast and Mold Count: Not detected
Research Applications
In controlled laboratory environments, BPC-157 / TB-500 may be utilised in experimental models designed to investigate peptide signalling systems and molecular interaction pathways. Examples of research applications include:- Peptide signalling investigations
- Molecular communication studies
- Comparative peptide research
- Signal transduction analysis
- Laboratory peptide interaction studies
- Molecular pathway modelling
- Controlled in vitro peptide research
Grail Formula Quality
Every Grail Formula research compound is supported by extensive independent analytical verification and complete batch traceability. Each batch undergoes testing for:- Compound identity confirmation
- Assay content verification
- Purity assessment
- Molecular mass verification
- Endotoxin analysis
- Microbial contamination screening
- Heavy metal screening
- Full batch traceability
When You Choose Grail Formula
When selecting Grail Formula, researchers receive access to independently verified research compounds supported by detailed Certificates of Analysis and transparent batch-specific testing. Our quality programme includes assay verification, purity confirmation, retention time identification, molecular ion mass identification, endotoxin screening, microbiological analysis and elemental impurity testing. Every batch is accompanied by a downloadable COA issued by Liquilabs s.r.o. Czechia, providing full traceability and independent laboratory verification.Research Use Limitation
- Used solely for laboratory and in vitro research
- Not approved for human consumption
- Not approved for veterinary use
- Not intended for diagnostic purposes
- Not intended for therapeutic applications
- Not permitted for clinical administration
- For research use only
- Independently analysed by Liquilabs s.r.o. Czechia
- BPC-157 purity confirmed at 99.2 %
- TB-500 purity confirmed above 99.8 %
- Assay content verified at 7.36 mg BPC-157
- Assay content verified at 6.11 mg TB-500
- Molecular ion mass identified at 1418 Da and 4963 Da
- Endotoxin level below 0.001 EU/mg
- No detectable heavy metals or microbial contamination
- Dual peptide research blend
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.
Third-Party Tested
Public COAs
Batch Verified
EU Shipping

